Statements of Cash Flows - USD ($)	4 Months Ended	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2021
Cash Flows from Operating Activities:
Net income (loss)	$ (1,018)	$ 7,152,775
Interest earned on investments held in Trust Account		(16,371)
Unrealized gain on change in fair value of warrants		(13,719,533)
Offering expenses related to warrant issuance		1,021,001
Loss on sale of private placement warrants		2,422,739
Changes in operating assets and liabilities:
Prepaid expenses		(260,959)
Due to related party		326
Accounts payable and accrued expenses	761	2,005,137
Net cash used in operating activities	(257)	(1,394,885)
Cash Flows from Investing Activities:
Marketable securities held in Trust Account		(275,000,000)
Net cash used in investing activities		(275,000,000)
Cash Flows from Financing Activities:
Proceeds from IPO, net of underwriters’ fees		269,500,000
Proceeds from private placement		7,500,000
Proceeds from issuance of promissory note to Sponsor	262,500	1,500,000
Repayment of promissory note to related party		(275,000)
Payments of offering costs	(88,050)	(496,025)
Net cash provided by financing activities	174,450	277,728,975
Net Change in Cash	174,193	1,334,090
Cash – Beginning of period		174,193
Cash – End of period	174,193	1,508,283
Non-cash investing and financing activities:
Deferred underwriting commissions charged to additional paid-in capital		9,625,000
Forfeiture of 25,000 shares by initial stockholders		2
Accretion of Class A common stock to redemption value		32,574,212
Deferred offering costs paid by Sponsor in exchange for issuance of Class B common stock	25,000
Deferred offering costs paid through promissory note – related party	$ 12,500